Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Sekisui Voltek is a premier manufacturer of cross-linked, closed-cell polyolefin foams, serving as a critical supplier to the healthcare, medical device, and pharmaceutical industries. The company specializes in high-performance materials such as Volara, Volextra, and VolaraBLOCK, which are engineered for applications requiring biocompatibility, moisture resistance, and sterilization compatibility. These foams are widely used in the production of electro-medical devices like EKG pads and electrodes, as well as in wound care, orthopedics, and transdermal drug delivery systems. Headquartered in Coldwater, Michigan, Sekisui Voltek operates as a subsidiary of Sekisui Chemical Co., Ltd., leveraging advanced irradiation and chemical cross-linking technologies to deliver customized foam solutions. The company maintains rigorous quality standards, including ISO 13485 certification, to meet the demanding requirements of global medical OEMs.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Voltek.